SSR2 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
B cell	41 studies	48% ± 14%	Explore
natural killer cell	38 studies	56% ± 12%	Explore
fibroblast	38 studies	56% ± 22%	Explore
CD8-positive, alpha-beta T cell	36 studies	55% ± 18%	Explore
endothelial cell	35 studies	44% ± 19%	Explore
CD4-positive, alpha-beta T cell	33 studies	58% ± 18%	Explore
T cell	32 studies	54% ± 16%	Explore
macrophage	31 studies	40% ± 13%	Explore
conventional dendritic cell	28 studies	55% ± 14%	Explore
pericyte	27 studies	48% ± 22%	Explore
regulatory T cell	26 studies	57% ± 15%	Explore
plasma cell	25 studies	63% ± 22%	Explore
classical monocyte	25 studies	44% ± 14%	Explore
smooth muscle cell	24 studies	45% ± 20%	Explore
plasmacytoid dendritic cell	24 studies	61% ± 14%	Explore
dendritic cell	23 studies	47% ± 22%	Explore
non-classical monocyte	23 studies	50% ± 16%	Explore
mature NK T cell	21 studies	53% ± 14%	Explore
memory B cell	20 studies	52% ± 9%	Explore
naive B cell	20 studies	43% ± 12%	Explore
epithelial cell	20 studies	53% ± 25%	Explore
monocyte	19 studies	43% ± 12%	Explore
gamma-delta T cell	19 studies	56% ± 16%	Explore
connective tissue cell	19 studies	63% ± 22%	Explore
mast cell	18 studies	46% ± 15%	Explore
endothelial cell of lymphatic vessel	18 studies	48% ± 16%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	18 studies	56% ± 17%	Explore
basal cell	18 studies	48% ± 20%	Explore
mucosal invariant T cell	16 studies	56% ± 16%	Explore
CD16-negative, CD56-bright natural killer cell, human	15 studies	54% ± 17%	Explore
CD16-positive, CD56-dim natural killer cell, human	15 studies	59% ± 13%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	14 studies	65% ± 12%	Explore
myofibroblast cell	14 studies	62% ± 23%	Explore
effector memory CD8-positive, alpha-beta T cell	12 studies	53% ± 20%	Explore
plasmablast	12 studies	75% ± 17%	Explore
CD4-positive, alpha-beta memory T cell	12 studies	59% ± 18%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	58% ± 17%	Explore
capillary endothelial cell	12 studies	38% ± 16%	Explore
myeloid cell	12 studies	44% ± 15%	Explore
secretory cell	11 studies	48% ± 14%	Explore
endothelial cell of artery	11 studies	42% ± 16%	Explore
goblet cell	11 studies	42% ± 18%	Explore
vein endothelial cell	11 studies	42% ± 17%	Explore
endothelial cell of vascular tree	11 studies	39% ± 9%	Explore
innate lymphoid cell	10 studies	52% ± 11%	Explore
abnormal cell	10 studies	58% ± 20%	Explore
mesothelial cell	10 studies	72% ± 25%	Explore
ciliated cell	10 studies	40% ± 15%	Explore
type II pneumocyte	9 studies	55% ± 23%	Explore
progenitor cell	9 studies	64% ± 19%	Explore
IgG plasma cell	9 studies	48% ± 18%	Explore
T follicular helper cell	9 studies	57% ± 13%	Explore
type I pneumocyte	8 studies	56% ± 18%	Explore
leukocyte	8 studies	48% ± 10%	Explore
IgA plasma cell	8 studies	52% ± 21%	Explore
hematopoietic stem cell	8 studies	56% ± 19%	Explore
club cell	7 studies	49% ± 20%	Explore
effector CD8-positive, alpha-beta T cell	7 studies	67% ± 18%	Explore
epithelial cell of proximal tubule	7 studies	34% ± 18%	Explore
neuron	7 studies	52% ± 27%	Explore
hematopoietic precursor cell	6 studies	57% ± 29%	Explore
respiratory goblet cell	6 studies	34% ± 25%	Explore
effector CD4-positive, alpha-beta T cell	6 studies	69% ± 23%	Explore
kidney loop of Henle epithelial cell	6 studies	28% ± 6%	Explore
enterocyte	6 studies	36% ± 14%	Explore
intestinal crypt stem cell	6 studies	39% ± 18%	Explore
precursor B cell	6 studies	47% ± 16%	Explore
effector memory CD4-positive, alpha-beta T cell	6 studies	67% ± 17%	Explore
alveolar macrophage	5 studies	31% ± 4%	Explore
CD4-positive helper T cell	5 studies	45% ± 10%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	54% ± 15%	Explore
exhausted T cell	5 studies	71% ± 11%	Explore
ionocyte	5 studies	37% ± 11%	Explore
neutrophil	5 studies	20% ± 4%	Explore
platelet	5 studies	23% ± 5%	Explore
mononuclear phagocyte	5 studies	54% ± 18%	Explore
enteroendocrine cell	5 studies	59% ± 24%	Explore
transit amplifying cell	5 studies	33% ± 15%	Explore
pro-B cell	5 studies	44% ± 12%	Explore
brush cell	5 studies	30% ± 18%	Explore
T-helper 17 cell	5 studies	64% ± 16%	Explore
group 3 innate lymphoid cell	5 studies	66% ± 11%	Explore
immature B cell	5 studies	56% ± 14%	Explore
double negative thymocyte	5 studies	67% ± 12%	Explore
granulocyte	5 studies	48% ± 12%	Explore
erythrocyte	5 studies	40% ± 12%	Explore
central memory CD8-positive, alpha-beta T cell	4 studies	57% ± 16%	Explore
pancreatic A cell	4 studies	73% ± 12%	Explore
type B pancreatic cell	4 studies	68% ± 15%	Explore
kidney distal convoluted tubule epithelial cell	4 studies	60% ± 25%	Explore
renal alpha-intercalated cell	4 studies	50% ± 22%	Explore
erythroblast	4 studies	38% ± 15%	Explore
adventitial cell	4 studies	57% ± 9%	Explore
mucus secreting cell	4 studies	50% ± 19%	Explore
acinar cell	4 studies	58% ± 18%	Explore
intermediate monocyte	4 studies	57% ± 24%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	63% ± 10%	Explore
luminal cell of prostate epithelium	4 studies	30% ± 10%	Explore
megakaryocyte-erythroid progenitor cell	4 studies	57% ± 27%	Explore
hepatocyte	4 studies	39% ± 28%	Explore
T-helper 1 cell	4 studies	70% ± 11%	Explore
CD4-positive, alpha-beta cytotoxic T cell	3 studies	63% ± 21%	Explore
deuterosomal cell	3 studies	20% ± 4%	Explore
duct epithelial cell	3 studies	46% ± 8%	Explore
precursor cell	3 studies	67% ± 19%	Explore
pancreatic D cell	3 studies	75% ± 12%	Explore
monocyte-derived dendritic cell	3 studies	53% ± 24%	Explore
glomerular endothelial cell	3 studies	28% ± 6%	Explore
neural crest cell	3 studies	75% ± 11%	Explore
thymocyte	3 studies	49% ± 26%	Explore
extravillous trophoblast	3 studies	88% ± 7%	Explore
placental villous trophoblast	3 studies	84% ± 7%	Explore
common myeloid progenitor	3 studies	51% ± 30%	Explore
lymphocyte	3 studies	55% ± 15%	Explore
megakaryocyte	3 studies	27% ± 3%	Explore
neuroendocrine cell	3 studies	57% ± 19%	Explore
astrocyte	3 studies	30% ± 16%	Explore
microglial cell	3 studies	34% ± 13%	Explore
serous secreting cell	3 studies	59% ± 20%	Explore
intraepithelial lymphocyte	3 studies	52% ± 14%	Explore
Mueller cell	3 studies	28% ± 8%	Explore
muscle cell	3 studies	37% ± 22%	Explore
germinal center B cell	3 studies	45% ± 5%	Explore
myoepithelial cell	3 studies	64% ± 15%	Explore
inflammatory macrophage	3 studies	33% ± 10%	Explore
IgM plasma cell	3 studies	63% ± 10%	Explore
GABAergic neuron	3 studies	24% ± 2%	Explore
glutamatergic neuron	3 studies	30% ± 1%	Explore
pancreatic ductal cell	3 studies	74% ± 3%	Explore
oligodendrocyte precursor cell	3 studies	47% ± 24%	Explore
granulocyte monocyte progenitor cell	3 studies	55% ± 26%	Explore
glial cell	3 studies	54% ± 29%	Explore
keratinocyte	3 studies	33% ± 6%	Explore
central memory CD4-positive, alpha-beta T cell	3 studies	67% ± 10%	Explore
double-positive, alpha-beta thymocyte	3 studies	78% ± 4%	Explore
progenitor cell of mammary luminal epithelium	3 studies	71% ± 8%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	20 studies	54% ± 15%	Explore
lung	18 studies	49% ± 19%	Explore
intestine	12 studies	47% ± 22%	Explore
kidney	9 studies	44% ± 19%	Explore
bone marrow	7 studies	35% ± 15%	Explore
brain	7 studies	27% ± 9%	Explore
lymph node	6 studies	53% ± 17%	Explore
liver	6 studies	40% ± 16%	Explore
pancreas	5 studies	61% ± 23%	Explore
placenta	5 studies	54% ± 27%	Explore
eye	5 studies	30% ± 11%	Explore
uterus	5 studies	54% ± 22%	Explore
prostate	4 studies	27% ± 8%	Explore
breast	4 studies	57% ± 8%	Explore
adrenal gland	3 studies	47% ± 14%	Explore
esophagus	3 studies	45% ± 33%	Explore
skin	3 studies	35% ± 10%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
liver	100%	6096.17	226 / 226	100%	94.51	406 / 406
lung	100%	9825.25	578 / 578	100%	98.57	1155 / 1155
ovary	100%	13262.90	180 / 180	100%	100.94	430 / 430
pancreas	100%	13528.57	328 / 328	100%	87.23	178 / 178
skin	100%	9642.12	1809 / 1809	100%	105.47	472 / 472
breast	100%	9373.25	459 / 459	100%	137.02	1117 / 1118
thymus	100%	5916.57	653 / 653	100%	64.21	604 / 605
intestine	100%	7661.39	966 / 966	100%	82.13	526 / 527
prostate	100%	8186.04	245 / 245	100%	126.89	501 / 502
uterus	100%	9855.38	170 / 170	100%	107.61	458 / 459
stomach	100%	7963.90	359 / 359	100%	73.49	285 / 286
bladder	100%	8360.95	21 / 21	99%	97.49	501 / 504
esophagus	100%	5563.97	1444 / 1445	99%	57.56	182 / 183
kidney	100%	7233.58	89 / 89	99%	73.48	892 / 901
brain	98%	3125.17	2592 / 2642	100%	60.70	703 / 705
adrenal gland	100%	13418.28	258 / 258	97%	54.28	223 / 230
adipose	100%	8631.60	1204 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	100%	77.95	80 / 80
lymph node	0%	0	0 / 0	100%	108.27	29 / 29
spleen	100%	9994.22	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	61.81	45 / 45
ureter	0%	0	0 / 0	100%	71.75	1 / 1
blood vessel	100%	6951.50	1334 / 1335	0%	0	0 / 0
peripheral blood	99%	10280.57	924 / 929	0%	0	0 / 0
heart	99%	4050.55	850 / 861	0%	0	0 / 0
muscle	96%	2617.10	771 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

IV. Literature review

[source]

Gene name	SSR2
Protein name	Translocon-associated protein subunit beta (TRAP-beta) (Signal sequence receptor subunit beta) (SSR-beta) Translocon-associated protein subunit beta Signal sequence receptor subunit 2
Synonyms	HSD25 TRAPB
Description	FUNCTION: TRAP proteins are part of a complex whose function is to bind calcium to the ER membrane and thereby regulate the retention of ER resident proteins. FUNCTION: TRAP proteins are part of a complex whose function is to bind calcium to the ER membrane and thereby regulate the retention of ER resident proteins. .
Accessions	ENST00000473699.5 ENST00000531790.5 ENST00000496742.5 ENST00000480567.5 E9PQ05 ENST00000529008.5 E9PQJ7 ENST00000531917.5 ENST00000466905.4 E9PNP2 E9PQI4 ENST00000295702.9 ENST00000526212.2 P43308 E9PJ35 ENST00000474377.5 E9PLP2 E9PN13

GO_0006613	Biological process	cotranslational protein targeting to membrane
GO_0005783	Cellular component	endoplasmic reticulum
GO_0016020	Cellular component	membrane
GO_0005789	Cellular component	endoplasmic reticulum membrane
GO_0005515	Molecular function	protein binding

SSR2 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review